Bharat Immunologicals & Biologicals Corporation Ltd (NSE: BIBCL), ISIN INE994B01014 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
BIBCL last traded at ₹15.47 (-2.21%), with a 52-week range of ₹14.10 to ₹23.19 (as of 30 Jul 2026).
Shareholding as of Mar 2024: promoters 59.25%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 41/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.